Paclitaxel 300 mg for intravenous injection Turkey
Interchangeable drugs with the same active ingredient:
Abitaxel
Viztaxel
Intaxel
Kanataxene
Mitotax
Mitotax-M
Neotaxel
Neotaxel-Health
Paclimedak
Paklinor 100
Paklinor 260
Paclitax
Paclitaxel "Ebewe"
Paclitaxel Actavis
Paclitaxel Amaxa
Paclitaxel Main
Paclitaxel-Vista
Paclitaxel-Lance
Paclitaxel-MB
Paclitaxel-Teva
Paclitaxel-Pharmex
Paclitero
packlihop
Paktalik
Pantium
Praxel
Streetoxol
Taxawal
Taxol
Taxomeda
Tapaklet
Egilitax
Syndaxel
Intaxel
Indications:
Ovarian cancer. First-line chemotherapy for advanced disease or residual tumors (greater than 1 cm) after laparotomy in combination with cisplatin.
Mammary cancer. Adjuvant chemotherapy in breast cancer patients with lymph node involvement after treatment with anthracyclines and cyclophosphamide; primary chemotherapy of locally advanced or metastatic breast cancer in combination with anthracyclines or in combination with trastuzumab in case of immunohistochemically detected overexpression of HER-2 (3+) oncoproteins or in the presence of contraindications to anthracycline therapy; monotherapy of metastatic breast cancer in patients who are not candidates for standard anthracycline therapy, or in case of failure of previous anthracycline therapy.
Extensive non-small cell lung cancer (NSCLC). Combination chemotherapy with cisplatin in case of impossibility of using surgical treatment and / or radiation therapy.
Kaposi's sarcoma in AIDS patients. Second-line therapy for advanced Kaposi's sarcoma in AIDS patients.
-
Commercial name:Taksen
-
Сhemical name:Paclitaxel
-
Dosage:300 mg
-
Quantity:one
-
Release form:Bottle
-
Производитель:KOCAK ILAC. Турция